Conference Coverage

Promising new tool for better migraine management in primary care


 

FROM AHS 2022

Lessons for clinical practice

Jessica Ailani, MD, director at MedStar Georgetown Headache Center and associate professor in the department of neurology at Georgetown University, cochaired the session in which the research was presented and called the project “really fantastic.”

The study offers “many lessons” for clinical practice and showed that the tool was effective in improving diagnosis of migraine, said Dr. Ailani, who is also secretary of the American Headache Society.

“There’s a long wait time to see specialists, and most migraine can be diagnosed and basic management can be done by primary care physicians,” she said.

“The next step would be to work on a way to improve prescriptions of migraine-specific treatments,” she added.

Dr. Ailani noted that the AHS would be keen to find ways to engage in “collaborative work” with the investigators.

The investigators and Dr. Ailani reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA approves first IV migraine prevention drug
Clinician Reviews
FDA OKs first orally disintegrating agent for rapid migraine relief
Clinician Reviews
Expert says progress in gut-brain research requires an open mind
Clinician Reviews
Researchers develop score to predict risk of stroke among migraineurs with aura
Clinician Reviews
A large proportion of migraine patients are not offered preventive treatment
Clinician Reviews
Pandemic survey: Forty-six percent of pediatric headache patients got worse
Clinician Reviews
Headache is a common post–COVID-19 complaint
Clinician Reviews
Is mindfulness key to helping physicians with mental health?
Clinician Reviews
About 19% of COVID-19 headaches become chronic
Clinician Reviews
Autoimmune disorder drugs top list of meds linked to headache
Clinician Reviews